INTICA Biomedical, Inc. — Form D/A
INTICA Biomedical, Inc. of LEXINGTON, MA, a company, filed a Form D amendment with the SEC on 2013-01-31. The offering totals $995K, of which $995K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-01-31
- Form: D/A
- Accession: 0001544878-13-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $995K
- Amount sold: $995K
- Minimum investment: $15K
- Investors: 16
- Date of first sale: 2012-03-05
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-175015
Issuer
- Name: INTICA Biomedical, Inc.
- CIK: 0001544878
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 23 BLUEBERRY LANE, LEXINGTON, MA, 02420
- Phone: (617) 538-8540
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Christine Bunt | Director | Fair Haven, NJ |
| Victoria Herrera, M.D. | Director | Westwood, MA |
| Nelson Ruiz-Opazo, Ph.D. | Director | Westwood, MA |
| Christine Bunt | Executive Officer | Fair Haven, NJ |
| Peter B Finn | Executive Officer | Boston, MA |
Other filings by this issuer (1)
More